Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy

Documenti analoghi

• Structural Basis for the Presentation of Tumor-associated MHC Class II-restricted Phosphopeptides to CD4(+) T Cells
  di: Li, Yili, et al.
  Pubblicazione: (2010)
• Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy
  di: Zarling, Angela L., et al.
  Pubblicazione: (2006)
• Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma
  di: Malaker, Stacy A., et al.
  Pubblicazione: (2016)
• Structure-based design of altered MHC II-restricted peptide ligands with heterogeneous immunogenicity()
  di: Chen, Shuming, et al.
  Pubblicazione: (2013)
• The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status
  di: Mohammed, Fiyaz, et al.
  Pubblicazione: (2017)